All In Biotech

Free tool

FAERS Monitor: Estrogel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021166 or its brand name (Estrogel, Estradiol). Reports on generic versions are filed under their own applications.

Reports

48,633

Serious

23,773

49% of reports

Hospitalization

7,526

Death reported

927

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,071
  • headache3,072
  • fatigue3,055
  • nausea3,045
  • off label use2,580
  • pain2,197
  • diarrhoea2,068
  • dizziness1,807
  • arthralgia1,787
  • breast cancer female1,713
  • dyspnoea1,640
  • pruritus1,619
  • rash1,606
  • product adhesion issue1,539
  • insomnia1,430

Reports by year received

View as table
YearReports
2004527
2005591
2006411
20071,475
2008446
2009610
2010972
2011861
20121,173
2013923
20141,144
20151,987
20162,435
20172,227
20182,589
20193,069
20203,111
20212,938
20223,162
20233,675
20243,849
20255,325
20265,132

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,005,526 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal1,71329.628.244,276
product adhesion issueSignal1,53919.418.525,759
insomniaSignal1,4302.32.21,091
headacheSignal3,0722.12.11,874
arthralgia1,7871.91.8724
pruritus1,6191.81.7612
fatigue3,0551.71.6910
nausea3,0451.71.6839
rash1,6061.61.5363
dizziness1,8071.61.5380
pain2,1971.51.5438
diarrhoea2,0681.41.3229
drug ineffective4,0711.31.3367
off label use2,5801.31.2159
dyspnoea1,6401.31.286

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.